SCHEMBL8092754

SCHEMBL8092754

CN(CCO)c1ccnc(CSc2nc3ccccc3[nH]2)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP2E1 P05181 1/20 0.49
CYP2C8 P10632 1/20 0.49
CYP2B6 P20813 1/20 0.49
RAB9A P51151 8/20 0.48
NPC1 O15118 7/20 0.48
CYP3A4 P08684 1/20 0.48
EPHX2 P34913 1/20 0.47
ALDH1A1 P00352 2/20 0.46
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
SMN1; SMN2 Q16637 7/20 0.44
BCHE P06276 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
GFER P55789 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8089224 0.94 CYP1A2 (0.47) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL7850659 0.91 CYP1A2 (0.50) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL7848644 0.90 CYP1A2 (0.49) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL8089221 0.90 CYP1A2 (0.49) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL7839642 0.89 CYP1A2 (0.48) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL7849333 0.87 CYP1A2 (0.47) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL7850736 0.85 RAB9A (0.47) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL7849930 0.85 RAB9A (0.47) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL7840322 0.84 RAB9A (0.47) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL7852559 0.84 HRH3 (0.52) CYP1A2CYP2D6CYP2C9CYP2C19CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043242-A TREATING A MAMMAL AFFLICTED WITH A DISEASE BASED ON HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-03-28 US disclosed
EP-0946559-A2 IMIDAZOPYRIDAZINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1999-10-06 EP disclosed
WO-1998028299-A2 IMIDAZOPYRIDAZINES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1998-07-02 WO disclosed